To the Editor.
—The carbonic anhydrase inhibitor acetazolamide is widely used to lower intraocular pressure. It also produces a mild, nonanion gap metabolic acidosis by interfering with the resorption of bicarbonate in the
Gabay EL. Metabolic Acidosis From Acetazolamide Therapy. Arch Ophthalmol. 1983;101(2):303–304. doi:10.1001/archopht.1983.01040010305028
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: